The pandemic has revealed how much the rest of the world has been left behind in terms of pharmaceutical/healthcare research. What models can you offer for kick-starting vibrant local financing of drug development in developing countries?
https://www.ncbi.nlm.nih.gov/books/NBK50972/
Dear Dr. Anyam!
I consider your question to be a highly important one, so I did search for YOU resources you might value:
1) Meganck, R.M., Baric, R.S. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med 27, 401–410 (2021). https://doi.org/10.1038/s41591-021-01282-0 Free access:
https://www.nature.com/articles/s41591-021-01282-0
2) Verguet, S., Hailu, A., Eregata, G.T. et al. Toward universal health coverage in the post-COVID-19 era. Nat Med 27, 380–387 (2021). https://doi.org/10.1038/s41591-021-01268-y Free access: https://www.nature.com/articles/s41591-021-01268-y
3) Fontecha, G., Sánchez, A.L. What Will Happen to Biomedical Research in Low-and-Middle Income Countries in the PostCOVID-19 World?. Curr Trop Med Rep 8, 1–5 (2021). https://doi.org/10.1007/s40475-020-00223-0 Free access: Article Dear Author
4) Anser, M.K., Khan, M.A., Zaman, K. et al. Financial development during COVID-19 pandemic: the role of coronavirus testing and functional labs. Financ Innov 7, 9 (2021). https://doi.org/10.1186/s40854-021-00226-4 Free access: Article Financial development during COVID-19 pandemic: the role of ...
Yours sincerely, Bulcsu Szekely
